1 
2 
3 
4 
5 
6 
7 
S 
9 
10 
11 
12 
13 
14 
15 
16 
i7 
18 
19 
20 
21 
22 
23 
24 
25 
“ (2) In the case of a license to authorize the conduct of 
a recombinant DXA activity described in subparagraph (A) 
of subsection (a) (4) , such a license may not be issued, 
amended, or renewed under this section unless the Secretary 
has provided the advisory committee established under sec- 
tion 481 with a reasonable opportunity to provide him its 
recommendations on the issuance, amendment, or renewal of 
such license. To the extent practicable, the Secretary shall 
consult with such advisory committee respecting applications 
for the issuance, amendment, or renewal of a license to au- 
thorize the conduct of a recombinant DXA activity described 
in subparagraph (B) of subsection (a)(4). 
“(d) The Secretary may revoke, suspend, or limit, a 
license issued under this section for a facility if he finds, after 
reasonable notice and opportunity for a hearing to the holder 
of the license, that the holder of the license, any employee 
or agent of the holder, or any person engaged in a recombi- 
nant DNA activity in such facility — 
“ ( 1 ) misrepresented any material fact in obtaining 
the license, 
“ (2) has engaged in or attempted to engage in, or 
represented itself as entitled to perform, any recombinant 
DNA activity not authorized by its license, 
“ (3) has failed to comply with any of the terms or 
conditions of the license, 
H.R. 7418 3 
[ 594 ] 
